FDA Media Alert Detail

Drug Shortage

FDA Drug Shortage: Atropine Sulfate Injection

  • U.S. Food and Drug Administration
  • August 24, 2026
  • ID: shortage-atropine-sulfate-injection-hospira-inc-a-pfizer-company-0409-9630-05

Drug Shortage Details

Generic NameAtropine Sulfate Injection
Manufacturer / CompanyHospira, Inc., a Pfizer Company
Therapeutic CategoryAnesthesia, Neurology, Pediatric
Availability StatusAvailable
Status (FDA list)Current
NDC Package Code0409-9630-05
Presentation & Dosage Form

Atropine Sulfate, Injection, 0.25 mg/5 mL (0.05 mg/mL) Syringes (NDC 0409-9630-05)

Manufacturer Contact Info

844-646-4398


Content syndicated from the U.S. Food and Drug Administration (FDA) Drug Shortages Database.